Continuing Education

The Cardiac Myosin Activator Omecamtiv Mecarbil Improves Left Ventricular Myocardial Deformation in Chronic Heart Failure (COSMIC-HF)

November 12, 2020 Editor

Circulation: Heart Failure, Ahead of Print.

← Pumping the Breaks on Health Care Costs of Cardiac Surgery by Focusing on Postacute Care Spending
Effects of Omecamtiv Mecarbil on Symptoms and Health-Related Quality of Life in Patients with Chronic Heart Failure: Results from the COSMIC-HF Study →